Executive Summary
Six filings in this India Corporate Insolvency & NCLT stream fall within scope for the period 2026-10-14, though the enriched fields (period-over-period comparisons, insider activity, capital allocation, forward-looking guidance, transaction valuations) are largely empty for these procedural disclosures, so the digest is driven by timeline, tribunal, and governance events rather than quantitative trends.
Four filings are newly published (Vas Infrastructure, Bajaj Healthcare, Siti Networks, AGS Transact) and two are context (Polycab India, Gangotri Textiles). The most material developments are the governance disruption at Siti Networks (RP registration cancelled by IBBI, replacement RP appointed on IndusInd Bank's application) and the admission of Gangotri Textiles' own Section 10 petition with board powers suspended. The Vas Infrastructure CIRP timetable slipped one week at each stage after applicant requests, signalling a process that is continuing but not accelerating. Bajaj Healthcare's NCLT-approved acquisition of Genrx Pharmaceuticals (in liquidation) is a going-concern asset deal with no disclosed consideration, so its valuation implications cannot be assessed. Across the group, the common thread is that tribunal timelines are the primary catalyst, with several hearings and CoC meetings clustered in mid-October to early December 2026.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Insolvency
Tracking the trend? Catch up on the prior India NCLT Insolvency Resolution Filings digest from October 13, 2026.
Investment Signals (7)
- Bajaj Healthcare ↓ (BULLISH)▲
NCLT Mumbai approved acquisition of Genrx Pharmaceuticals (in liquidation) on a going-concern basis via order dated 13 Oct 2026, becoming a wholly owned subsidiary; no consideration disclosed, so accretion cannot be quantified
- Vas Infrastructure ↓ (NEUTRAL)▲
CIRP timetable extended one week at each stage (EoI deadline 13 to 20 Oct, resolution plan deadline 23 to 30 Nov) after applicant requests, indicating active bidder interest rather than a stalled process
- AGS Transact Technologies ↓ (NEUTRAL)▲
19th CoC meeting rescheduled to 15 Oct 2026, 2:00 p.m. via video conferencing; routine scheduling but a near-term decision point in the CIRP
- Polycab India ↓ (NEUTRAL)▲
NCLAT granted early listing of Asier Metals' appeal, now set for 15 Oct 2026 (fourth related intimation since 7 Oct); the procedural acceleration is a near-term event with no quantified exposure disclosed
- Siti Networks ↓ (NEUTRAL)▲
NCLT order dated 28 Sep 2026 appointed new RP on IndusInd Bank's application after IBBI cancelled prior RP's registration; Joint Lender Meeting approved new RP with 72% vote, indicating lender consensus behind the change
- Gangotri Textiles ↓ (BEARISH)▲
NCLT Chennai admitted Section 10 petition (CP(IB) 310/CHE/2025) and appointed G. Gunasekaran as IRP effective 7 Aug 2026, with board and committee powers suspended; control has fully transferred to the IRP
- Siti Networks ↓ (BEARISH)▲
Next NCLT hearing listed for 3 Dec 2026, with the new RP's AFA valid only until 31 Dec 2026, creating a time-bound window for operational continuity
Risk Flags (6)
- Siti Networks/Governance Disruption↓ [HIGH RISK]▼
Prior RP's registration cancelled by IBBI (disciplinary order IBBI/DC/338/2026 dated 6 Aug 2026, effective 6 Sep 2026); replacement RP needed, adding process risk and potential delay
- Gangotri Textiles/Full Control Transfer↓ [HIGH RISK]▼
Board and committee powers suspended from 7 Aug 2026 under Section 10 admission; management no longer controls the company's decisions and the filing discloses no debt, asset, or revenue figures to size the exposure
- Vas Infrastructure/Timeline Slippage↓ [MEDIUM RISK]▼
Every stage of the resolution timetable moved by one week (EoI, provisional list, objections, final list, IM issuance), with the final resolution plan deadline now 30 Nov 2026; repeated extensions raise the risk of further slippage
- Polycab India/Pending Appeal↓ [MEDIUM RISK]▼
Asier Metals appeal against the company before NCLAT is being heard on an accelerated basis (15 Oct 2026); the filing gives no quantified financial impact, so the contingent liability cannot be sized
- ▼
19th CoC meeting shifted to 15 Oct 2026 at 2:00 p.m.; schedule changes in CIRP can signal procedural friction among creditors
- Bajaj Healthcare/Target Liquidation Status↓ [LOW RISK]▼
Genrx Pharmaceuticals is in liquidation, and the trading window for designated persons remains closed per the 23 Sep 2026 disclosure, limiting insider transparency during the acquisition's implementation
Opportunities (5)
- Vas Infrastructure/Resolution Plan Pipeline↓ (OPPORTUNITY)◆
Provisional list of prospective resolution applicants due 23 Oct, objections 28 Oct, final list 30 Oct, IM and RFRP issued 31 Oct 2026; positioning ahead of the final list is the key window for prospective bidders
- Bajaj Healthcare/Genrx Integration↓ (OPPORTUNITY)◆
Going-concern acquisition of Genrx Pharmaceuticals adds a pharmaceutical asset to Bajaj's healthcare platform; implementation of NCLT terms is the catalyst to monitor for valuation clarity
- AGS Transact/CoC Decision↓ (OPPORTUNITY)◆
19th CoC meeting on 15 Oct 2026 may resolve pending creditor decisions; outcome could define the resolution pathway and equity recovery for shareholders
- Polycab India/Appeal Resolution↓ (OPPORTUNITY)◆
NCLAT hearing on 15 Oct 2026 could conclude the Asier Metals matter, removing an overhang on an otherwise operating business; a favourable ruling would be a positive event
- Siti Networks/Lender-Backed Recovery↓ (OPPORTUNITY)◆
IndusInd Bank-initiated process with 72% lender approval for the new RP suggests a credible lender-led recovery framework; the 3 Dec 2026 hearing is the next checkpoint
Sector Themes (4)
- Tribunal-Driven Timeline Risk Across CIRP Cases◆
Of the six filings, four (Vas Infrastructure, AGS Transact, Siti Networks, Polycab India) feature schedule changes, extensions, or accelerated hearings, indicating that NCLT and NCLAT timelines are the dominant near-term variable across insolvency situations [IMPLICATION: Investors should price procedural timing risk into event-driven positions and track the mid-October to early-December 2026 calendar closely]
- Governance Transfer as the Default Outcome of Insolvency◆
Gangotri Textiles (board powers suspended) and Siti Networks (RP replacement) show that once insolvency is admitted, management control shifts quickly to IRP/RP, with shareholder influence minimal; equity holders should treat control as lost at admission [IMPLICATION: Equity recovery depends almost entirely on the resolution plan outcome rather than on operational management]
- Going-Concern Acquisitions of Liquidation Assets◆
Bajaj Healthcare's acquisition of Genrx (in liquidation) on a going-concern basis reflects a broader pattern of acquirers picking up viable businesses out of liquidation; no consideration was disclosed, limiting valuation comparison [IMPLICATION: Acquirer returns depend on post-approval integration rather than headline price]
- Lender-Led Governance in Large Insolvencies◆
Siti Networks' Joint Lender Meeting approval (72% vote) and IndusInd Bank as applicant reflect creditor-driven control of process selection [IMPLICATION: Lender consensus is the key gating factor for RP appointments and plan approvals]
Watch List (6)
-
Hearing on 15 Oct 2026; outcome determines whether this contingent matter is resolved or extended
-
Video conference on 15 Oct 2026 at 2:00 p.m.; watch for resolution-pathway decisions
-
EoI deadline 20 Oct; provisional list 23 Oct; objections 28 Oct; final list 30 Oct; RFRP 31 Oct; resolution plan deadline 30 Nov 2026
-
Listed for 3 Dec 2026; new RP's AFA valid through 31 Dec 2026, so watch for either an extension or a change of RP
-
NCLT order effective 13 Oct 2026 until further orders; watch for implementation disclosures and the lifting of the trading window closure
-
IRP appointed 7 Aug 2026 with board powers suspended; watch for the constitution of the Committee of Creditors and the invitation for resolution plans
Filing Analyses
(6)
14-10-2026
VAS Infrastructure Limited, under Corporate Insolvency Resolution Process (CIRP) with Mr. Bimal Kumar Agarwal as Resolution Professional, has published a corrigendum to its Form G Expression of Interest, extending all key resolution timelines. The last date for receipt of EoI moves from October 13, 2026 to October 20, 2026, and the last date for submission of resolution plans moves from November 23, 2026 to November 30, 2026. The extension follows requests from prospective applicants, so the process is continuing rather than stalling, but the timetable has slipped by one week at each stage.
- · Revised timeline: provisional list of prospective resolution applicants moves to October 23, 2026; objections due October 28, 2026; final list October 30, 2026; information memorandum and request for resolution plans issued October 31, 2026
- · The corrigendum was published in Free Press Journal (English) and Navshakti (Marathi), Mumbai editions; the company states it is available on its website and the IBBI website
- · The NCLT Mumbai Bench order approving the RP appointment is IA No. 3523 of 2026 in C.P. (IB) No. 314/MB/2023, dated August 13, 2026
- · Filing date discrepancy: the 'date of the event' in the table is stated as September 14, 2026, while the corrigendum itself and the letter reference publication on October 14, 2026
- · Expression of Interest submission email: [email protected] (letter) versus [email protected] in the table; the asset in the sale is a real estate project in Borivali West, Mumbai
14-10-2026
Bajaj Healthcare Limited disclosed that the Hon'ble NCLT Mumbai Bench, by order dated October 13, 2026, approved the acquisition of Genrx Pharmaceuticals Private Limited (in Liquidation) on a going concern basis, to become a wholly owned subsidiary subject to implementation of the NCLT order terms. The order is effective from October 13, 2026 until further orders, and the company's trading window remains closed for designated persons per the September 23, 2026 disclosure. The filing does not disclose any transaction value, consideration, or financial figures.
- · Order dated October 13, 2026 by NCLT Mumbai Bench; company downloaded it from the NCLT website on October 13, 2026
- · Genrx Pharmaceuticals will become a Wholly Owned Subsidiary of Bajaj Healthcare, subject to implementation of NCLT order terms
- · Trading window for designated persons and immediate relatives remains closed, per the September 23, 2026 disclosure
- · No aberrations, non-compliances, penalties, or restrictions were identified by the authority
14-10-2026
SITI Networks Limited disclosed, via a Regulation 30 filing dated October 14, 2026, that the Hon'ble NCLT Mumbai Bench, by order dated September 28, 2026 (received October 12, 2026), appointed Mr. Trupalkumar Patel as Resolution Professional under Section 7 of the IBC, 2016, on an application by IndusInd Bank Ltd. The appointment followed the IBBI's cancellation of the prior RP's registration (disciplinary order dated August 6, 2026, effective September 6, 2026) and a Joint Lender Meeting on September 16, 2026, which approved the new RP with 72% voting. The matter is listed for next hearing on December 3, 2026.
- · The prior Resolution Professional's registration was cancelled by IBBI disciplinary order No. IBBI/DC/338/2026 dated August 6, 2026, which became effective September 6, 2026
- · The Joint Lender Meeting held September 16, 2026 approved the new RP's appointment, with the new RP's authorization for exercise (AFA) valid up to December 31, 2026
- · The matter is listed for next hearing on December 3, 2026
- · The filing is a continuation of the company's earlier disclosure dated October 13, 2026
14-10-2026
AGS Transact Technologies Limited, currently under the Corporate Insolvency Resolution Process (CIRP), has rescheduled its 19th Committee of Creditors (CoC) meeting to Thursday, 15 October 2026 at 2:00 p.m. via video conferencing. The disclosure is made under Regulation 30 of the SEBI (LODR) Regulations, 2015, and is issued by the Deemed Resolution Professional, Brijendra Kumar Mishra.
- · The 19th CoC meeting was rescheduled to Thursday, 15 October 2026 at 2:00 p.m. via video conferencing
- · Filing reference: IRP/AGS/M/26-27/1792, dated 14 October 2026
- · BSE Scrip Code: 543451; NSE Symbol: AGSTRA
- · Resolution Professional's IBBI Registration No: IBBI/IPA-002/IP-N00109/2017-2018/10257; AFA valid till 31 December 2026
14-10-2026
Polycab India Limited disclosed under Regulation 30 of SEBI (LODR) Regulations, 2015 an update on an appeal filed by Asier Metals Private Limited against the company, which was listed before the Hon'ble NCLAT, Principal Bench, New Delhi. The NCLAT granted a request for early listing, and the appeal is now scheduled to be heard on October 15, 2026. The filing is procedural in nature and includes no quantified financial impact.
- · The appeal was originally listed for hearing on October 26, 2026, and was advanced to October 14, 2026 for an early hearing request, with the hearing now set for October 15, 2026.
- · This is the fourth related intimation, following earlier disclosures dated October 07, 2026, October 08, 2026 and October 09, 2026.
14-10-2026
Gangotri Textiles Ltd disclosed that the National Company Law Tribunal (NCLT), Chennai, admitted the company's own Section 10 petition for Corporate Insolvency Resolution Process (CIRP) by an order dated 7 August 2026, appointing Mr. G. Gunasekaran as Interim Resolution Professional (IRP). Under the order, the powers of the Board of Directors and Committees stand suspended from 7 August 2026, and Mr. Gunasekaran replaces Mr. Manoj Kumar Tibrewal as Compliance Officer. The filing contains no financial figures on debt, assets, or revenue.
- · Insolvency petition filed under Section 10 of the IBC, case reference CP(IB) 310/CHE/2025, before NCLT Chennai
- · Mr. G. Gunasekaran is registered with the IBBI under Regn No. IBBI/IPA-001/IP-P00681/2017-2018/11178
- · Board and committee powers suspended with effect from 7 August 2026, with control transferred to the IRP
- · Filing dated 14 October 2026 was made under Regulation 30 of SEBI LODR Regulations, 2015, with a 7-week lag between the order date and disclosure
Get daily alerts with 7 investment signals, 6 risk alerts, 5 opportunities and full AI analysis of all 6 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India NCLT Insolvency Resolution Filings
October 12, 2026
India NCLT Insolvency Resolution Filings — October 12, 2026
October 10, 2026
India NCLT Insolvency Resolution Filings — October 10, 2026
October 09, 2026
India NCLT Insolvency Resolution Filings — October 09, 2026
October 08, 2026
India NCLT Insolvency Resolution Filings — October 08, 2026
🇮🇳 More from India
View all →October 15, 2026
India Upcoming Corporate Actions BSE NSE — October 15, 2026
India Upcoming Corporate Actions BSE NSE
October 15, 2026
India Quarterly Results BSE NSE Announcements — October 15, 2026
India Quarterly Results BSE NSE Announcements
October 15, 2026
India Pre-Market Regulatory Roundup — October 15, 2026
India Pre-Market Regulatory Roundup
October 15, 2026
India RBI Monetary Policy Repo Rate Decisions — October 15, 2026
India RBI Monetary Policy Repo Rate Decisions